New and emerging targeted treatments in advanced lung cancer

Fred R. Hirsch (Aurora, United States of America)

Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management
Session: Lung cancer: latest developments in screening and patient management
Session type: Lunchtime session
Number: 2906

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fred R. Hirsch (Aurora, United States of America). New and emerging targeted treatments in advanced lung cancer. International Congress 2016 – Lung cancer: latest developments in screening and patient management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New and anticipated therapeutic developments in management of non-small-cell lung cancer
Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer
Year: 2013


Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Innovative local therapies in lung cancer
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018


A preliminary study on targeted therapies in advanced lung cancer patients
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Novel approaches in metastasised non-small cell lung cancer with a special focus on modern systemic therapies
Source: International Congress 2019 – State of the art session: Thoracic oncology
Year: 2019


New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches
Source: Virtual Congress 2021 – Thoracic oncology
Year: 2021


Current neoadjuvant/adjuvant treatment for advanced stage lung cancer
Source: International Congress 2014 – PG19 Surgery for advanced stage lung cancer
Year: 2014

New chemotherapeutic agents
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=259
Year: 2001

Advances in target therapy for lung cancer
Source: International Congress 2014 – Ceremony for the ERS Romain Pauwels Research Award 2014 - Clinical Year in Review I
Year: 2014



Advances in target therapy in lung cancer
Source: Eur Respir Rev 2015; 24: 23-29
Year: 2015



Precision medicine for lung cancer: new targeted treatments 
Source: International Congress 2017 – Precision medicine approaches in lung cancer
Year: 2017


Lung disease induced by newer therapies for lung cancer: an update
Source: Annual Congress 2006 - Drug-induced lung injury – new aspects
Year: 2006


New techniques for early detection of lung cancer
Source: Eur Respir J 2003; 21: 57S-66S
Year: 2003



Modern profiling of advanced lung cancer at the primary diagnosis and during therapy
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006

Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1119-1133
Year: 2013



Innovative systemic lung cancer therapies
Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy
Year: 2018